Wilentin 300 mg, Hartkapseln

7680679000025 CH-67900 Kapseln

Associated product:

WILENTIN caps 300 mg bte 100 pce
Wilentin 300 mg, Hartkapseln
Wilentin 300 mg, Hartkapseln
Wilentin 300 mg, Hartkapseln
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/01/2023
Patient information leaflet
Français
16/01/2023
Patient information leaflet
Italien
16/01/2023
Summary of Product Characteristics
Allemand
16/01/2023
Summary of Product Characteristics
Français
16/01/2023
Summary of Product Characteristics
Italien
16/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
67900
Drug name
Wilentin, Hartkapseln
Galenic form
KAHA
ATC Code
A16AX12
Authorization status
Z
Dispensing category
B
First authorization
08/12/2021
Authorization expiration date
07/12/2026
IT Number
07.99.0.
Domain
Human medicine
Field of application
Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen

Package details

Description (FR)
WILENTIN caps 300 mg bte 100 pce
Description (DE)
WILENTIN Kaps 300 mg Ds 100 Stk
Market launch
08/12/2021
Narcotic (BTM)
No

Other package sizes (1)

WILENTIN caps 250 mg bte 100 pce
100 KAP
GTIN: 7680679000018
View